Monopar Therapeutics
MNPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645469
In the last 90 days, Monopar Therapeutics insiders filed 0 open-market purchases and 3 sales; 95 institutions reported holding it in 13F filings for Q2 2026, worth $576.1M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Monopar Therapeutics insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 3 filings
- 3 insiders, $807.5K in total
- Insiders trading
- 3
- Net value
- −$807.5K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Monopar Therapeutics, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Tsuchimoto Kim R | Director | 0 | Aug 28, 2026 | 2 |
| Anderson Raymond | Director | 5,373 | Aug 28, 2026 | 2 |
| Rioux Patrice | Other: Acting Chief Medical Officer | 5,065 | Aug 27, 2026 | 2 |
| Vu Quan Anh | Chief Financial Officer | 2,221 | Jul 2, 2026 | 3 |
| Robinson Chandler | Chief Executive Officer | 99,267 | Jul 2, 2026 | 6 |
| Cittadine Andrew | Chief Operating Officer | 55,614 | Jul 2, 2026 | 5 |
| Sweeny Nicole | Director | – | Jun 30, 2026 | 1 |
| Rodriguez Susan | CCSO | – | Mar 4, 2026 | 1 |
| Klausner Arthur J | Director | 8,762 | Dec 19, 2025 | 3 |
| Hendricks Diane | 10% Owner | 567,580Indirect | Dec 17, 2025 | 1 |
| Starr Christopher M | Director | 5,173 | Dec 8, 2025 | 1 |
| Talukdar Lavina | Director | – | Dec 8, 2025 | 1 |
| Brown Michael J | Other: Member of 10% Owner Group | 272,026 | Sep 26, 2025 | 0 |
| Tactic Pharma LLC | 10% Owner | 272,026 | Sep 26, 2025 | 0 |
| Mazar Andrew Paul | Other: Member of 10% Owner Group | 272,026 | Sep 26, 2025 | 0 |
| O'Halloran Thomas V. | Other: Member of 10% Owner Group | 272,026 | Sep 26, 2025 | 0 |
| TacticGem LLC | 10% Owner | 0 | Dec 17, 2024 | 0 |
| Radhakrishnan Karthik | Chief Financial Officer | 1,550 | Oct 30, 2024 | 0 |
| Filho Jose Octavio Pinto Costa | Chief Medical Officer | – | Jul 13, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 (view filing)8:18 PM ET | Aug 26 | 2 days | Tsuchimoto Kim RDirector | SSale | −4.09K | $111.39 | −$455.6K | −100.0%0 after | Amended6 lots10b5-1 |
| Aug 28, 2026 (view filing)7:41 PM ET | Aug 25 | 3 days | Anderson RaymondDirector | SSale | −3.14K | $111.98 | −$351.8K | −36.9%5.37K after | Amended3 lots10b5-1 |
| Aug 27, 2026 (view filing)7:29 PM ET | Aug 26 | 1 day | Rioux PatriceOther: Acting Chief Medical Officer | SSale | −1 | $111.26 | −$111.26 | 0.0%5.07K after | 10b5-1 |
| Dec 29, 2025 (view filing) | Dec 26 | 3 days | Vu Quan AnhChief Financial Officer | PPurchase | +1.50K | $69.95 | +$104.9K | New position1.50K after | |
| Dec 19, 2025 (view filing) | Dec 18 | 1 day | Klausner Arthur JDirector | SSale | −5.12K | $67.15 | −$343.9K | −36.9%8.76K after | 2 lots |
| Sep 26, 2025 (view filing)3:53 PM ET | Sep 24 | 2 days | Robinson Chandler and 4 othersChief Executive Officer | SSale | −550.2K | $63.61 | −$35.0M | −66.9%272.0K after | |
| Jul 16, 2025 (view filing)9:06 PM ET | Jul 14 | 2 days | Tsuchimoto Kim RDirector | SSale | −8.90K | $40.00 | −$356.2K | −43.7%11.5K after | |
| Jul 16, 2025 (view filing)9:03 PM ET | Jul 14 | 2 days | Starr Christopher MDirector | SSale | −16.8K | $40.00 | −$672.0K | −76.5%5.17K after | |
| Jul 16, 2025 (view filing)9:02 PM ET | Jul 14 | 2 days | Robinson ChandlerChief Executive Officer | SSale | −16.8K | $40.00 | −$672.0K | −18.6%73.5K after | |
| Apr 4, 2025 (view filing)7:27 PM ET | Apr 2 | 2 days | Robinson Chandler and 4 othersChief Executive Officer | SSale | −33.3K | $35.00 | −$1.17M | −3.9%822.3K after | |
| Oct 30, 2024 (view filing) | Oct 28 | 2 days | Radhakrishnan KarthikChief Financial Officer | PPurchase | +1.55K | $16.25 | +$25.2K | New position1.55K after | |
| Jun 21, 2024 (view filing) | Jun 18-20 | 3 days | Cittadine AndrewChief Operating Officer | PPurchase | +32.5K | $0.7843 | +$25.5K | +21.2%186.1K after | 2 lots |
| Jun 17, 2024 (view filing) | Jun 13-17 | 4 days | Cittadine AndrewChief Operating Officer | PPurchase | +36.0K | $0.9133 | +$32.9K | +30.6%153.6K after | 3 lots |
| Jun 5, 2024 (view filing) | Jun 3-4 | 2 days | Cittadine AndrewChief Operating Officer | PPurchase | +24.0K | $0.77 | +$18.5K | +25.6%117.6K after | 2 lots |
| May 31, 2024 (view filing) | May 29-31 | 2 days | Cittadine AndrewChief Operating Officer | PPurchase | +36.0K | $0.64 | +$23.0K | +62.5%93.6K after | 3 lots |
| Nov 16, 2022 (view filing) | Nov 14-15 | 2 days | Cittadine AndrewChief Operating Officer | PPurchase | +16.1K | $3.09 | +$49.7K | +196.1%24.2K after | 2 lots |